Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$547.09 +4.59 (+0.85%)
At close: Nov 6, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Return on Sales [ROS] (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) posted Return on Sales [ROS] of 20.72% for Q3 2026, down 17.84 percentage points from 38.56% a year earlier and down 16.68 percentage points from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Vertex Pharmaceuticals was 33.23%, down 0.83 percentage points year-over-year; for FY2025, it came in at 34.77%, up 36.89 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of -11.25 percentage points (FY2020 to FY2025).
  • In prior years, Vertex Pharmaceuticals' Return on Sales [ROS] was -2.11% in FY2024 (-40.94 pp), 38.83% in FY2023 (-9.40 pp), 48.23% in FY2022 (+11.50 pp) and 36.73% in FY2021 (-9.30 pp).
  • The Q3 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q2 2024.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of +18.12 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 171.68 percentage points; the weakest was Q2 2024, with a drop of 174.02 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 37.40% (Q2 2026), 38.10% (Q1 2026) and 37.80% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 24.35%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 36.01%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 29.12%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 41.71%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 32.98%
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 20.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.72%
Jun 30, 2026 37.40%
Mar 31, 2026 38.10%
Dec 31, 2025 37.80%
Sep 30, 2025 38.56%
Jun 30, 2025 38.83%
Mar 31, 2025 22.75%
Dec 31, 2024 35.23%
Sep 30, 2024 40.27%
Jun 30, 2024 -132.85%
Mar 31, 2024 42.35%
Dec 31, 2023 39.26%
Sep 30, 2023 41.80%
Jun 30, 2023 41.17%
Mar 31, 2023 32.80%
Dec 31, 2022 44.88%
Sep 30, 2022 48.27%
Jun 30, 2022 50.37%
Mar 31, 2022 49.63%
Dec 31, 2021 42.35%
API Access

Vertex Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEY